Theodoros Foukakis

23PUBLICATIONS
125CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisTumour immunologyNgā tikanga mātauranga o te Māori (Māori educational methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Apr 08, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial.

Alexios Matikas, Evangelos Tzoras, Michail Sarafidis

|Dec 30, 2025
Variation in Pathological Appearance Across Repeated Sampling from Probably Benign Breast Lesions.

Athanasios Zouzos, Irma Fredriksson, Theodoros Foukakis

|Mar 07, 2025
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.

Ioannis Zerdes, Alexios Matikas, Artur Mezheyeuski

|Sep 16, 2024
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.

Peter Schmid, Javier Cortes, Rebecca Dent

|Jul 17, 2024
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.

Alexios Matikas, Volker Möbus, Richard Greil

Pageof 4

Frequent Collaborators

8 joint publications

Alexios Matikas

7 joint publications

Jonas Bergh

6 joint publications

Ioannis Zerdes

5 joint publications

Balazs Acs